Cargando…

Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation

BACKGROUND: Since stroke patients with nonvalvular atrial fibrillation (NVAF) have poor outcomes in general, the prediction of outcomes following discharge is of utmost concern for these patients. We previously reported that brain natriuretic peptide (BNP) levels were significantly higher in NVAF pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maruyama, Kenji, Uchiyama, Shinichiro, Shiga, Tsuyoshi, Iijima, Mutsumi, Ishizuka, Kentaro, Hoshino, Takao, Kitagawa, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465753/ https://www.ncbi.nlm.nih.gov/pubmed/28253498 http://dx.doi.org/10.1159/000457808

Ejemplares similares

Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson’s Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance
por: Iijima, Mutsumi, et al.
Publicado: (2017)

Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review
por: Iijima, Mutsumi, et al.
Publicado: (2015)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis
por: Saito, Satoshi, et al.
Publicado: (2023)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Natriuretic peptides as predictors for atrial fibrillation recurrence after catheter ablation: A meta-analysis
por: Yuan, Yujing, et al.
Publicado: (2023)

Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source
por: Ishizuka, Kentaro, et al.
Publicado: (2022)

Effects of Pemafibrate in Patients with Stroke and Hypertriglyceridemia: Baseline Cerebral Artery Diseases and 3-Month Laboratory Outcomes
por: Hoshino, Takao, et al.
Publicado: (2022)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Atrial Natriuretic Peptide Single Nucleotide Polymorphisms in Patients with Nonfamilial Structural Atrial Fibrillation
por: Francia, Pietro, et al.
Publicado: (2013)

Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White?
por: Richards, Arthur Mark
Publicado: (2019)

Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria
por: Rahbar Kouibaran, Farzad, et al.
Publicado: (2023)

Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study
por: Hoshino, Takao, et al.
Publicado: (2022)

Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study
por: Shiga, Tsuyoshi, et al.
Publicado: (2015)

Plasma B-type Natriuretic Peptide as a Predictor of Cardiovascular Events in Subjects with Atrial Fibrillation: A Community-Based Study
por: Nakamura, Motoyuki, et al.
Publicado: (2013)

Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide
por: Tokudome, Takeshi, et al.
Publicado: (2022)

Interplay between natriuretic peptides and left atrial mechanics and the relation to recurrence of atrial fibrillation following catheter ablation
por: Olsen, Flemming Javier, et al.
Publicado: (2023)

Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes
por: Toi, Sono, et al.
Publicado: (2022)

Characteristics and Prognosis of Stroke in Living Donor Renal Transplant Recipients
por: Mizuno, Takafumi, et al.
Publicado: (2022)

Hyperhomocysteinemia Increases Vascular Risk in Stroke Patients with Chronic Kidney Disease
por: Mizuno, Takafumi, et al.
Publicado: (2023)

Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia – the Find-AF Study
por: Wachter, Rolf, et al.
Publicado: (2012)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
por: Brady, Paul F., et al.
Publicado: (2022)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

ScaI atrial natriuretic peptide gene polymorphisms and their possible association with postoperative atrial fibrillation – a preliminary report
por: Siebert, Janusz, et al.
Publicado: (2016)

Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation
por: Miake, Junichiro, et al.
Publicado: (2018)

The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial
por: Weng, Willy, et al.
Publicado: (2021)

Predicting Successful Pulmonary Vein Isolation In Patients With Atrial Fibrillation By Brain Natriuretic Peptide Plasma Levels
por: Shin, Dong-In, et al.
Publicado: (2009)

Clinical Significance of B-Type Natriuretic Peptide Levels at 3 Months after Atrial Fibrillation Ablation
por: Matsumoto, Sen, et al.
Publicado: (2021)

Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score
por: Seewöster, Timm, et al.
Publicado: (2020)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Perampanel improved intractable myoclonus in two patients with myoclonus epilepsy
por: Iijima, Mutsumi, et al.
Publicado: (2019)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Relationship of Natriuretic Peptides with Left Atrial Structure and Function within 1 Month after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation
por: Karaliute, Rasa, et al.
Publicado: (2019)

Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells
por: Nojiri, Takashi, et al.
Publicado: (2015)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Perioperative predictors of atrial fibrillation
por: İşcan, Şahin, et al.
Publicado: (2018)

Electrocardiographic Predictors of Atrial Fibrillation
por: Chousou, Panagiota Anna, et al.
Publicado: (2023)

Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020)

Japanese and Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: A Five-Year Risk Analysis of Stroke and Vascular Events
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b1ajdbbp2lpi738r362d21tcbg